Agilent Technologies (NYSE: A) — Perfil da empresa, notícias e dados financeiros
Agilent Technologies specializes in life sciences and diagnostics, offering analytical instruments and solutions for laboratory workflows.
Agilent Technologies
Agilent Technologies is a global provider of analytical instruments, software, services, consumables, and diagnostics solutions for life sciences, clinical diagnostics, and applied chemical markets. Spun off from Hewlett-Packard in 1999, the company manufactures liquid and gas chromatography systems, mass spectrometers, molecular biology reagents, and tissue pathology tools. Its products serve laboratories engaged in pharmaceutical drug discovery, bioanalytical testing, clinical diagnostics, food safety verification, environmental monitoring, and materials research. Headquartered in Santa Clara, California, Agilent maintains administrative offices, research facilities, and production plants across North America, Europe, and Asia-Pacific to support laboratory workflows globally.
Resumo
Operações
Produtos e/ou serviços de Agilent Technologies
- Life Sciences Instrumentation: High-performance gas and liquid chromatography systems, mass spectrometers, and atomic spectroscopy instruments designed for drug discovery, pharmaceutical quality control, academic research, and structural biology analysis across global analytical testing laboratories.
- Agilent CrossLab Services: Comprehensive laboratory enterprise services, analytical instrument maintenance, enterprise asset management, regulatory compliance support, and workflow consulting designed to optimize laboratory operations and equipment uptime across pharmaceutical and industrial facilities.
- Diagnostics and Pathology Solutions: Reagents, primary antibodies, automated immunohistochemistry instruments, molecular pathology assays, and tissue staining platforms supplied to hospital and independent clinical pathology laboratories for precision cancer diagnostics and companion diagnostic development.
- Chromatography Consumables and Supplies: Sample preparation kits, liquid and gas chromatography columns, microfluidics components, specialized vials, and laboratory reagents engineered to enable precise chemical separation, sample cleanup, and sample handling across analytical testing workflows.
- Genomics and Automation Systems: Next-generation sequencing library preparation automation, microfluidic nucleic acid analysis platforms, target enrichment assays, target capture reagents, and quantitative PCR systems utilized in clinical genomics and life science research applications.
- Applied Markets Instrumentation: Specialized chemical testing equipment, gas chromatographs, and spectroscopy instruments deployed in industrial facilities for food safety testing, environmental water and air monitoring, petrochemical analysis, and forensic analysis.
equipe executiva do Agilent Technologies
- Padraig McDonnellCEO, President & Director
- Rodney GonsalvesVice President of Finance
- Angelica A. RiemannSenior VP & President of Agilent CrossLab Group
- Simon MaySenior VP and President of Life Sciences & Diagnostics Markets Group
- Bret M. DiMarcoSpecial Advisor
- Adam S. ElinoffSenior VP, CFO & Principal Financial Officer
- Tim DownsVP & Chief Accounting Officer
- August SpechtSenior VP & Chief Technology Officer
- Tejas Rajeev SavantVice President of Investor Relations
- Michael BucknerSenior VP, Chief Legal Officer & Secretary
Histórico de dividendos
Dividendos por ação pagos pela Agilent Technologies, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $1.0200 |
| FY2025 | — | — | — | $0.9920 |
| FY2024 | — | — | — | $0.9440 |
| FY2023 | — | — | — | $0.9000 |
| FY2022 | — | — | — | $0.8400 |
Principais indicadores financeiros
Resultados divulgados pela Agilent Technologies, em USD.
- Cap. de mercado
- 50 bi
- Receita (TTM)
- 7,4 bi
- P/L
- 35.0
- LPA (diluído, TTM)
- 5.1
- Dividend yield
- 0.6%
- Margem de lucro
- 19.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 6,9 bi | 1,5 bi | 1,3 bi | |
| 6,5 bi | 1,5 bi | 1,3 bi | |
| 6,8 bi | 1,4 bi | 1,2 bi | |
| 6,8 bi | 1,6 bi | 1,3 bi |